INVO Bioscience (NASDAQ:INVO) Shares Down 4.5% – Here’s Why

Shares of INVO Bioscience, Inc. (NASDAQ:INVO) were down 4.5% during mid-day trading on Monday . The stock traded as low as $0.81 and last traded at $0.81. Approximately 19,996 shares changed hands during trading, a decline of 99% from the average daily volume of 1,587,563 shares. The stock had previously closed at $0.85.

INVO Bioscience Stock Performance

The firm has a fifty day simple moving average of $0.79 and a 200-day simple moving average of $0.83.

Hedge Funds Weigh In On INVO Bioscience

An institutional investor recently bought a new position in INVO Bioscience stock. CWC Advisors LLC. purchased a new position in shares of INVO Bioscience, Inc. (NASDAQ:INVO) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 100,477 shares of the company’s stock, valued at approximately $71,000. CWC Advisors LLC. owned about 2.64% of INVO Bioscience as of its most recent SEC filing. Institutional investors and hedge funds own 12.02% of the company’s stock.

INVO Bioscience Company Profile

INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.